ORIC · Forms 3, 4, 5
Insider trades at Oric Pharmaceuticals, Inc.
2 insiders sold $276K of Oric Pharmaceuticals, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Oric Pharmaceuticals, Inc. (ORIC) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Richard A. Heyman | Director | Option exercise | 3,500 | $1.60 | $6K | Form 4 | |
| Richard A. Heyman | Director | Sell | 3,500 | $12.91 | $45K | Form 4 | |
| Richard A. Heyman | Director | Sell | 3,200 | $12.91 | $41K | Form 4 | |
| Dominic Piscitelli | Chief Financial Officer | Option exercise | 13,400 | $4.36 | $58K | Form 4 | |
| Dominic Piscitelli | Chief Financial Officer | Sell | 13,400 | $13.53 | $181K | Form 4 | |
| Dominic Piscitelli | Chief Financial Officer | Option exercise | 600 | $4.36 | $3K | Form 4 | |
| Dominic Piscitelli | Chief Financial Officer | Sell | 100 | $13.50 | $1K | Form 4 | |
| Dominic Piscitelli | Chief Financial Officer | Sell | 500 | $13.51 | $7K | Form 4 | |
| Dominic Piscitelli | Chief Financial Officer | Option exercise | 52,000 | $4.36 | $227K | Form 4 | |
| Dominic Piscitelli | Chief Financial Officer | Option exercise | 25,000 | $6.00 | $150K | Form 4 | |
| Dominic Piscitelli | Chief Financial Officer | Sell | 77,000 | $13.69 | $1.1M | Form 4 | |
| Richard A. Heyman | Director | Option exercise | 3,500 | $1.60 | $6K | Form 4 | |
| Richard A. Heyman | Director | Sell | 7,000 | $12.02 | $84K | Form 4 | |
| Richard A. Heyman | Director | Sell | 6,100 | $12.02 | $73K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.